Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Dialogues in Clinical Neuroscience|October 29, 2011
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacologyHanns MöhlerAdvances in Pharmacology (San Diego, Calif.)|January 21, 2015
The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autismHanns MöhlerJournal of Neurochemistry|March 31, 2007
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptorsHanns MöhlerBiochemical Pharmacology|August 18, 2012
Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome modelHanns MöhlerJournal of Receptor and Signal Transduction Research|November 23, 2006
GABAA receptors in central nervous system disease: anxiety, epilepsy, and insomniaHanns MöhlerNeuropharmacology|September 6, 2011
The GABA system in anxiety and depression and its therapeutic potentialHanns MöhlerNeurochemical Research|April 10, 2014
Endogenous benzodiazepine site peptide ligands operating bidirectionally in vivo in neurogenesis and thalamic oscillationsHanns MöhlerF1000Research|July 6, 2019
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilienceBernhard Lüscher, Hanns MöhlerPageof 4